Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy

FR Weth, GB Hoggarth, AF Weth, E Paterson… - British Journal of …, 2024 - nature.com
High rates of failure, exorbitant costs, and the sluggish pace of new drug discovery and
development have led to a growing interest in repurposing “old” drugs to treat both common …

Alzheimer's disease drug development pipeline: 2023

J Cummings, Y Zhou, G Lee, K Zhong… - … Research & Clinical …, 2023 - Wiley Online Library
Introduction Drugs that prevent the onset, slow progression, or improve cognitive and
behavioral symptoms of Alzheimer's disease (AD) are needed. Methods We searched …

Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities

EOJ Porta, K Kalesh, PG Steel - Frontiers in pharmacology, 2023 - frontiersin.org
Chagas disease is a vector-borne illness caused by the protozoan parasite Trypanosoma
cruzi (T. cruzi). It poses a significant public health burden, particularly in the poorest regions …

Carbonic anhydrase inhibitors as novel antibacterials in the era of antibiotic resistance: where are we now?

A Nocentini, C Capasso, CT Supuran - Antibiotics, 2023 - mdpi.com
Resistance to antibiotic treatment developed by bacteria in humans and animals occurs
when the microorganisms resist treatment with clinically approved antibiotics. Actions must …

The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?

AA Ezat, JM Abduljalil, AM Elghareib… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Drugs that have demonstrated good activity against any member of the
Orthopoxvirus genus are good candidates for repurposing studies against the mpox virus …

Drug repurposing for glomerular diseases: an underutilized resource

MSY Ng, G Kaur, RS Francis, CM Hawley… - Nature Reviews …, 2024 - nature.com
Drug repurposing in glomerular disease can deliver opportunities for steroid-free regimens,
enable personalized multi-target options for resistant or relapsing disease and enhance …

[HTML][HTML] Network-based drug repurposing for HPV-associated cervical cancer

F Ahmed, YJ Yang, A Samantasinghar, YW Kim… - Computational and …, 2023 - Elsevier
In women, cervical cancer (CC) is the fourth most common cancer around the world with
average cases of 604,000 and 342,000 deaths per year. Approximately 50% of high-grade …

Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs

A Greco, F Coperchini, L Croce, F Magri… - Frontiers in …, 2023 - frontiersin.org
Cancer represents the main cause of death worldwide. Thyroid cancer (TC) shows an
overall good rate of survival, however there is a percentage of patients that do not respond …

Drug repurposing against antibiotic resistant bacterial pathogens

M Aggarwal, A Patra, I Awasthi, A George… - European Journal of …, 2024 - Elsevier
The growing prevalence of MDR and XDR bacterial pathogens is posing a critical threat to
global health. Traditional antibiotic development paths have encountered significant …

From cancer big data to treatment: Artificial intelligence in cancer research

Danishuddin, S Khan, JJ Kim - The journal of gene medicine, 2024 - Wiley Online Library
In recent years, developing the idea of “cancer big data” has emerged as a result of the
significant expansion of various fields such as clinical research, genomics, proteomics and …